Cargando…
Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
Cytochrome P450 (CYP) 1A enzymes are considerably expressed in the human intestine and liver and involved in the biotransformation of about 10% of marketed drugs. Despite this doubtless clinical relevance, CYP1A1 and CYP1A2 are still somewhat underestimated in terms of unwanted side effects and drug...
Autores principales: | Klomp, Florian, Wenzel, Christoph, Drozdzik, Marek, Oswald, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764576/ https://www.ncbi.nlm.nih.gov/pubmed/33322313 http://dx.doi.org/10.3390/pharmaceutics12121201 |
Ejemplares similares
-
Intestinal drug transporters in pathological states: an overview
por: Drozdzik, Marek, et al.
Publicado: (2020) -
Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
por: Drozdzik, Marek, et al.
Publicado: (2021) -
Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?
por: Wenzel, Christoph, et al.
Publicado: (2021) -
Protein Abundance of Drug Metabolizing Enzymes in Human Hepatitis C Livers
por: Drozdzik, Marek, et al.
Publicado: (2023) -
Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure
por: Szeląg-Pieniek, Sylwia, et al.
Publicado: (2021)